August 28, 2015
More than 500 researchers from academia, government, and industry gather to gain perspective on biomarker development and the application of biomarkers in preclinical and clinical research.
August 14, 2015
Collaborative study helps validate effectiveness of FDA’s bioequivalence standard, showing no significant differences between major brand name and generic medication used to treat patients with epilepsy.
August 7, 2015
Graduate program co-founder Dr. Frank Palumbo assumes leadership of program, allowing previous director, Dr. Ebere Onukwugha, to focus on her work as executive director of the department’s Pharmaceutical Research Computing center.
August 6, 2015
Testimony examined the impact of FDA-supported research in generic drugs and advocated for continued funding through renewal of the Generic Drug User Fee Amendments of 2012 (GDUFA).
July 16, 2015
Pharmaceutical health services researchers, in collaboration with the National Organization for Rare Disorders (NORD), will design, implement, and evaluate an educational program for NORD members
May 22, 2015
Longtime School faculty members assume leadership of pharmaceutical sciences and pharmacy practice and science.
April 2, 2015
NIH-funded study focuses on novel means of bacterial identification that could provide hospitals with a more rapid and accurate assessment of infections.
March 30, 2015
Pharmacist and business owner Cal Knowlton recognized by APhA for his contributions to the pharmacy profession.
March 4, 2015
Findings published in AJMC show higher rates of hospitalization in heart failure patients on Medicaid; authors advocate for pharmacists’ involvement in managing medications
March 3, 2015
Study led by PHSR faculty member shows that 31 states have implemented prior authorization policies for atypical antipsychotic prescribing.
February 27, 2015
Paper from Eleanor Perfetto, PhD, reviews current PFDD activities and offers suggestions for incorporating patient input into drug development.
February 24, 2015
Interdisciplinary group will research the effectiveness of brand versus generic iron medications used to treat anemia in kidney disease patients
